AbbVie IncNYSE:ABBV
- LAST PRICE160.3950
- TODAY'S CHANGE (%)-1.1250 (-0.6965%)
- Bid / Lots160.3100/ 2
- Ask / Lots160.4800/ 2
- Open / Previous Close161.2700 / 161.5200
- Day Range
- 52 Week Range
- Volume235,634
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ABBV |
|---|---|---|
| 09:32 ET | 3220 | 161.02 |
| 09:34 ET | 61563 | 161.105 |
| 09:36 ET | 12834 | 161.185 |
| 09:38 ET | 8725 | 160.76 |
| 09:39 ET | 27565 | 160.385 |
| 09:41 ET | 23649 | 159.96 |
| 09:43 ET | 27281 | 159.82 |
| 09:45 ET | 6143 | 159.83 |
| 09:48 ET | 10037 | 160.395 |
Yesterday
DJ AbbVie Is Maintained at Overweight by Barclays, from 22 hours ago by Dow Jones
22 hours ago by Dow JonesDJ AbbVie Is Maintained at Outperform by BMO Capital, from 23 hours ago by Dow Jones
23 hours ago by Dow Jones
Apr 26, 2024
DJ AbbVie Shares Close Down 4.6%, Sees Additional Humira Volume Erosion in 2Q, from 4:38PM ET on Friday Apr 26, 2024 by Dow Jones
4:38PM ET on Friday Apr 26, 2024 by Dow JonesDJ AbbVie Lifts Outlook After 1Q Revenue Unexpectedly Rises, from 8:10AM ET on Friday Apr 26, 2024 by Dow Jones
8:10AM ET on Friday Apr 26, 2024 by Dow JonesDJ AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop -- Barrons.com, from 8:04AM ET on Friday Apr 26, 2024 by Dow Jones
8:04AM ET on Friday Apr 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
AbbVie Inc | 286.0B | 59.0x | -6.05% |
Merck & Co Inc | 329.6B | 146.3x | -43.23% |
AstraZeneca PLC | 232.8B | 37.3x | +17.52% |
Novartis AG | 212.9B | 22.1x | -5.59% |
Roche Holding AG | 198.3B | 15.3x | +3.28% |
Sanofi SA | 124.2B | 25.7x | +4.55% |
Company Information
AbbVie Inc. is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica, Venclexta/Venclyxto, Epkinly and Elahere; aesthetics products, which include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, which include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy and Qulipta; eye care products, which consists of Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis and Other eye care, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies and independent retailers.
Contact Information
- Headquarters
- 1 N Waukegan RdNORTH CHICAGO, IL, United States 60064
- Phone
- 847-932-7900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Richard Gonzalez
- Chief Executive Officer, Director
- Robert Michael
- Chief Financial Officer, Executive Vice President
- Scott Reents
- Chief Human Resource Officer, Executive Vice President
- Timothy Richmond
- Executive Vice President, General Counsel, Company Secretary
- Perry Siatis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $286.0B |
|---|---|
Revenue (TTM) | $54.3B |
Shares Outstanding | 1.8B |
Dividend Yield | 3.87% |
Annual Dividend Rate | 6.2000 USD |
Ex-Dividend Date | 04-12-24 |
Pay Date | 05-15-24 |
Beta | 0.59 |
EPS | $2.72 |
Book Value | $5.87 |
P/E Ratio | 59.0x |
Price/Sales (TTM) | 5.3 |
Price/Cash Flow (TTM) | 21.0x |
Operating Margin | 23.49% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
